Baseline characteristics according to aortic PP
| All | Low aortic PP | High aortic PP | P value | |
| (n=1894) | (n=856) | (n=1038) | ||
| Age, years | 51.2±12.4 | 44.1±10.7 | 57.1±10.6 | <0.001 |
| Female, n (%) | 1261 (66.6) | 445 (52.0) | 816 (78.6) | <0.001 |
| SBP, mm Hg | 130.4±22.8 | 113.2±11.7 | 144.6±19.8 | <0.001 |
| DBP, mm Hg | 74.6±10.5 | 72.7±9.4 | 76.2±11.0 | <0.001 |
| Pulse pressure, mm Hg | 55.8±18.4 | 40.5±6.6 | 68.4±15.2 | <0.001 |
| Hypertension, n (%) | 801 (42.3) | 254 (29.7) | 547 (52.7) | <0.001 |
| Diabetes mellitus, n (%) | 204 (10.8) | 68 (7.9) | 136 (13.1) | <0.001 |
| Dyslipidaemia, n (%) | 1046 (55.2) | 408 (47.7) | 638 (61.5) | <0.001 |
| Chronic kidney disease, n (%) | 258 (13.6) | 81 (8.7) | 181 (18.0) | <0.001 |
| Previous MI, n (%) | 258 (14.0) | 114 (13.7) | 144 (14.3) | 0.751 |
| Previous vascular disease, n (%) | 170 (9.0) | 66 (7.7) | 104 (10.0) | 0.095 |
| Current smoker, n (%) | 228 (12.0) | 138 (16.1) | 90 (8.7) | <0.001 |
| Body mass index, kg/m2 | 29.0±6.3 | 29.1±6.3 | 28.9±6.2 | 0.469 |
| Ejection fraction (%) | 61.6±7.3 | 61.3±7.1 | 61.8±7.6 | 0.226 |
| WBC, 103 /mm3 | 6.8±2.1 | 6.9±2.2 | 6.6±2.1 | 0.009 |
| Haemoglobin, g/L | 135.5±14.2 | 138.7±14.4 | 132.8±12.3 | <0.001 |
| Total cholesterol, mg/dL | 186.2±43.1 | 182.7±41.8 | 189.0±43.9 | 0.002 |
| TrIglyceride, mg/dL | 133.0±88.6 | 131.7±89.4 | 134.0±88.0 | 0.591 |
| HDL, mg/dL | 54.3±17.6 | 51.2±17.0 | 56.8±17.7 | <0.001 |
| LDL-C, mg/dL | 105.5±37.2 | 105.5±36.4 | 105.5±37.9 | 0.998 |
| BUN, mg/dL | 14.8±4.9 | 14.3±4.7 | 15.2±5.0 | 0.001 |
| Creatinine, mg/dL | 1.0±0.3 | 1.0±0.3 | 1.0±0.3 | 0.044 |
| eGFR (EPI), mL/min/1.73 m2 | 78.6±17.7 | 84.1±16.8 | 74.2±17.1 | <0.001 |
| NT-pro-BNP, pg/mL | 147.2±373.2 | 122.5±326.2 | 170.5±411.8 | 0.096 |
| hs-CRP, mg/L | 2.6±6.2 | 2.9±6.5 | 2.4±5.9 | 0.205 |
| Aspirin, n (%) | 918 (48.5) | 382 (44.6) | 536 (51.6) | 0.003 |
| ACE or ARB, n (%) | 271 (14.3) | 106 (12.4) | 165 (15.9) | 0.035 |
| β-blocker, n (%) | 579 (30.6) | 229 (26.8) | 350 (33.7) | 0.001 |
| Calcium channel blocker, n (%) | 576 (30.4) | 246 (28.7) | 330 (31.8) | 0.165 |
| Nitrate, n (%) | 750 (39.6) | 323 (37.7) | 427 (41.1) | 0.144 |
| ASCVD risk score | 4.9±7.4 | 2.3±3.3 | 7.5±9.2 | <0.001 |
Continuous variables were expressed in mean±SD as indicated.
ARB, angiotensin II receptor blocker; ASCVD, atherosclerotic cardiovascular disease; BUN, blood urea nitrogen; DBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate; EPI, epidemiology collaboration; HDL, high-density lipoprotein; hs-CRP, high sensitivity C reactive protein; LDL, low density lipoprotein; MI, myocardial infarction; NT-pro-BNP, N-terminal pro b-type natriuretic peptide; PP, pulse pressure; SBP, systolic blood pressure; WCC, white cell count.